Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Performance Score | Market Cap | Revenue | EBITDA | Earnings | EPS | Revenue Growth Y/Y | Revenue Growth 5Y | Earnings Growth Y/Y | Earnings Growth 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GLYC | GLYCOMIMETICS INC | $19.27M | $10.00k | -$36.35M | -$37.28M | -$0.58 | -86.67% | N/A | N/A | N/A | ||
| INTZ | INTRUSION INC | $7.99M | $5.43M | -$8.78M | -$10.87M | -$8.00 | -22.42% | -13.48% | N/A | N/A | ||
| ASLN | ASLAN PHARMACEUTICALS LTD | $8.29M | $12.00M | N/A | -$35.03M | -$1.75 | N/A | 31.95% | N/A | N/A | ||
| PPBT | PURPLE BIOTECH LTD | $10.99M | $0.00 | $22.27M | $19.88M | N/A | N/A | -100.00% | N/A | N/A | 2024-06-14 | |
| BPTH | BIO-PATH HOLDINGS INC | $3.54M | $0.00 | -$13.78M | -$13.96M | -$26.11 | N/A | N/A | N/A | N/A | ||
| IQ | IQIYI INC | $5.05B | $4.35B | N/A | $271.46M | $0.28 | -0.20% | 1.55% | 809.68% | N/A | ||
| CLNN | CLENE INC | $47.52M | $620.00k | -$41.91M | -$48.81M | -$0.46 | 12.73% | N/A | N/A | N/A | ||
| BIOL | BIOLASE INC | $5.31M | $48.83M | -$15.50M | -$38.26M | -$20.34 | 0.13% | 1.00% | N/A | N/A | ||
| APLM | APOLLOMICS INC | $29.71M | $0.00 | -$171.77M | -$172.60M | -$2.32 | N/A | N/A | N/A | N/A | ||
| LIFE | ATYR PHARMA INC | $138.02M | $588.00k | -$51.17M | -$53.93M | -$0.90 | -94.34% | N/A | N/A | N/A | 2024-06-05 | |
| GOSS | GOSSAMER BIO INC | $157.00M | $0.00 | -$155.21M | -$172.58M | -$1.00 | N/A | N/A | N/A | N/A | ||
| LYRA | LYRA THERAPEUTICS INC | $23.35M | $1.68M | -$68.69M | -$68.88M | -$1.20 | 28.74% | N/A | N/A | N/A | 2024-06-13 | |
| OCUP | OCUPHIRE PHARMA INC | $43.68M | $19.01M | -$11.28M | -$11.30M | -$0.48 | -54.30% | N/A | N/A | N/A | ||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $46.62M | $0.00 | -$40.07M | -$40.09M | -$1.59 | N/A | N/A | N/A | N/A | ||
| MVST | MICROVAST HOLDINGS INC | $130.37M | $341.00M | -$69.40M | -$101.58M | -$0.32 | 58.75% | N/A | N/A | N/A | 2024-06-04 | |
| VIRX | VIRACTA THERAPEUTICS INC | $31.69M | $0.00 | -$43.83M | -$47.99M | -$1.23 | N/A | N/A | N/A | N/A | 2024-06-18 | |
| CKPT | CHECKPOINT THERAPEUTICS INC | $69.28M | $68.00k | -$52.32M | -$52.32M | -$2.77 | -61.14% | -54.57% | N/A | N/A | ||
| APTO | APTOSE BIOSCIENCES INC | $19.25M | $0.00 | -$46.73M | -$47.17M | -$6.20 | N/A | N/A | N/A | N/A | ||
| SYBX | SYNLOGIC INC | $19.32M | $3.21M | -$68.01M | -$73.22M | -$7.96 | 188.74% | 5.06% | N/A | N/A | 2024-06-14 | |
| DARE | DARE BIOSCIENCE INC | $49.03M | $2.82M | -$28.77M | -$28.87M | -$0.32 | -71.83% | N/A | N/A | N/A | ||
| FEMY | FEMASYS INC | $28.22M | $1.05M | -$13.45M | -$14.90M | -$0.84 | -11.00% | N/A | N/A | N/A | ||
| IMRX | IMMUNEERING CORP | $43.59M | $0.00 | -$53.41M | -$54.18M | -$1.87 | -100.00% | N/A | N/A | N/A | ||
| CLDI | CALIDI BIOTHERAPEUTICS INC | $11.61M | $0.00 | -$27.77M | -$29.98M | -$0.69 | N/A | N/A | N/A | N/A | 2024-05-29 | |
| LUMO | LUMOS PHARMA INC | $20.62M | $1.53M | -$37.12M | -$37.13M | -$4.59 | -27.48% | -9.94% | N/A | N/A | 2024-05-31 | |
| MIST | MILESTONE PHARMACEUTICALS INC | $92.67M | $0.00 | -$51.60M | -$55.09M | -$1.25 | -100.00% | N/A | N/A | N/A | 2024-06-13 | |
| TARA | PROTARA THERAPEUTICS INC | $63.62M | $0.00 | -$42.12M | -$42.47M | -$3.74 | N/A | N/A | N/A | N/A | ||
| GOEV | CANOO INC | $190.62M | $886.00k | -$295.04M | -$323.44M | $2.10 | N/A | N/A | -57.40% | N/A | ||
| CVKD | CADRENAL THERAPEUTICS INC | $6.58M | $0.00 | -$4.84M | -$4.85M | -$0.31 | N/A | N/A | N/A | N/A | ||
| GNLX | GENELUX CORP | $98.54M | $8.00k | -$25.42M | -$25.78M | -$0.97 | -99.93% | N/A | N/A | N/A | ||
| CARA | CARA THERAPEUTICS INC | $41.01M | $16.94M | -$117.75M | -$122.54M | -$2.26 | -60.83% | -1.04% | N/A | N/A | ||
| INAB | IN8BIO INC | $45.45M | $0.00 | -$28.50M | -$31.04M | -$0.91 | N/A | N/A | N/A | N/A | ||
| GEVO | GEVO INC | $166.07M | $17.13M | -$46.43M | -$67.47M | -$0.29 | 242.39% | -11.20% | N/A | N/A | 2024-05-21 | |
| SONN | SONNET BIOTHERAPEUTICS HOLDINGS INC | $5.73M | $92.73k | -$8.35M | -$8.43M | -$2.31 | -53.29% | -68.21% | N/A | N/A | ||
| MRNS | MARINUS PHARMACEUTICALS INC | $73.06M | $28.29M | -$129.08M | -$145.34M | -$2.64 | 30.53% | N/A | N/A | N/A | 2024-05-22 | |
| TPST | TEMPEST THERAPEUTICS INC | $70.65M | $0.00 | -$26.24M | -$29.76M | -$1.72 | N/A | N/A | N/A | N/A | 2024-06-13 | |
| EOSE | EOS ENERGY ENTERPRISES INC | $148.60M | $14.14M | -$148.45M | -$204.61M | -$1.40 | -39.71% | N/A | N/A | N/A | 2024-06-12 | |
| DDC | DDC ENTERPRISE LTD | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| AMPX | AMPRIUS TECHNOLOGIES INC | $129.43M | $10.71M | -$32.92M | -$37.56M | -$0.43 | 259.64% | N/A | N/A | N/A | ||
| SPRB | SPRUCE BIOSCIENCES INC | $30.87M | $10.13M | -$47.11M | -$46.75M | -$1.13 | 415.63% | N/A | N/A | N/A | 2024-05-22 | |
| ACET | ADICET BIO INC | $131.48M | $0.00 | -$130.23M | -$139.79M | -$2.94 | N/A | -100.00% | N/A | N/A | 2024-06-05 | |
| CMPS | COMPASS PATHWAYS PLC | $536.11M | $0.00 | -$122.97M | -$129.44M | -$2.35 | N/A | N/A | N/A | N/A | ||
| VOR | VOR BIOPHARMA INC | $123.55M | $0.00 | -$112.63M | -$120.23M | -$1.77 | N/A | N/A | N/A | N/A | 2024-05-23 | |
| AQMS | AQUA METALS INC | $49.25M | $25.00k | -$23.12M | -$25.08M | -$0.24 | 525.00% | -62.01% | N/A | N/A | ||
| MBRX | MOLECULIN BIOTECH INC | $11.74M | $0.00 | -$26.70M | -$26.82M | -$13.04 | N/A | N/A | N/A | N/A | 2024-06-14 | |
| SGMT | SAGIMET BIOSCIENCES INC | $147.44M | $2.00M | -$27.78M | -$27.92M | -$38.69 | N/A | N/A | N/A | N/A | ||
| NTBL | NOTABLE LABS LTD | $9.20M | $311.00k | -$11.19M | -$12.22M | -$5.05 | N/A | -13.47% | N/A | N/A | ||
| CMMB | CHEMOMAB THERAPEUTICS LTD | $11.96M | $0.00 | N/A | -$19.34M | -$1.56 | N/A | N/A | N/A | N/A | ||
| IKNA | IKENA ONCOLOGY INC | $69.01M | $3.85M | -$67.40M | -$70.09M | -$1.57 | -78.07% | N/A | N/A | N/A | 2024-06-07 | |
| PGEN | PRECIGEN INC | $348.34M | $5.44M | -$90.64M | -$96.91M | -$0.39 | -76.60% | -47.32% | N/A | N/A | ||
| FBIO | FORTRESS BIOTECH INC | $38.44M | $85.11M | -$31.95M | -$62.86M | -$6.10 | 32.48% | 25.39% | N/A | N/A | 2024-05-21 | |
| CDTX | CIDARA THERAPEUTICS INC | $51.14M | $46.38M | -$35.16M | -$36.47M | -$8.08 | -44.42% | N/A | N/A | N/A | 2024-06-21 | |
| OTLK | OUTLOOK THERAPEUTICS INC | $182.10M | $0.00 | -$156.86M | -$159.13M | -$11.41 | N/A | -100.00% | N/A | N/A | ||
| AGEN | AGENUS INC | $228.05M | $161.42M | -$114.19M | -$239.61M | -$12.64 | 69.94% | 7.01% | N/A | N/A | ||
| SBEV | SPLASH BEVERAGE GROUP INC | $13.49M | $14.57M | -$19.17M | -$21.95M | -$0.49 | -27.10% | N/A | N/A | N/A | 2024-06-04 | |
| ATAI | ATAI LIFE SCIENCES NV | $286.26M | $277.00k | -$29.43M | -$33.80M | -$0.21 | 2.97% | N/A | N/A | N/A | ||
| HOOK | HOOKIPA PHARMA INC | $80.64M | $53.55M | -$43.89M | -$47.52M | -$0.50 | 235.12% | 40.26% | N/A | N/A | ||
| RIGL | RIGEL PHARMACEUTICALS INC | $166.64M | $120.35M | -$10.98M | -$19.80M | -$0.11 | -7.12% | 16.07% | N/A | N/A | ||
| CRBU | CARIBOU BIOSCIENCES INC | $306.18M | $33.40M | -$109.36M | -$115.26M | -$1.46 | 127.41% | N/A | N/A | N/A | ||
| PRST | PRESTO AUTOMATION INC | $17.37M | $21.20M | -$48.24M | -$66.42M | -$1.31 | -30.61% | N/A | N/A | N/A | ||
| CLRB | CELLECTAR BIOSCIENCES INC | $118.30M | $0.00 | -$50.75M | -$50.98M | -$3.08 | N/A | N/A | N/A | N/A | ||
| LCTX | LINEAGE CELL THERAPEUTICS INC | $203.90M | $8.00M | -$22.96M | -$23.66M | -$0.13 | -32.48% | 8.94% | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.